Fate Therapeutics, Inc. (NASDAQ: FATE) a clinical-stage biopharmaceutical company which develops programmed cellular immunotherapies for cancer and immune disorders worldwide, reported on Friday positive interim clinical data from the Company’s FT516 and FT596 programs for patients with relapsed / refractory...
Putman Investments revealed Thursday it will be acquiring Toys 'R' Us and Babies 'R' Us Canada from Fairfax Financial Holdings Ltd. The investment company already...
The United States has signaled its intent to extend the restrictions on non-essential travel between borders with Canada and Mexico. The decision comes as many...
Chipotle Mexican Grill (NYSE: CMG) has reported that its latest menu innovation, Plant-Based Chorizo is being tested in Denver and Indianapolis. This is the company’s...
Despite coming to an agreement with Ottawa on an aid package worth approximately $5.9 billion, the Company has failed to fully utilize the package and...
Macy's, Inc. (NYSE: M) stock jumped more than 15% on Thursday, after the retail store reported results for the second quarter of 2021, raised guidance...
Oct 21, 2021 by MarketDepth